Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
about
Metabolic syndrome and renal cell carcinomaAnimal models of metabolic syndrome: a reviewPatients with old age or proximal tumors benefit from metabolic syndrome in early stage gastric cancer.Association of body mass index with bladder cancer risk: a dose-response meta-analysis of prospective cohort studiesObesity and risk of bladder cancer: a dose-response meta-analysis of 15 cohort studies.Rodent models for metabolic syndrome research.Oxidative DNA damage in kidneys and heart of hypertensive mice is prevented by blocking angiotensin II and aldosterone receptors.Visceral adiposity, insulin resistance and cancer risk.Metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control studyThe association between metabolic syndrome and the risk of urothelial carcinoma of the bladder: a case-control study in China.Effect of hypertension on outcomes of high-risk patients after BCG-treated bladder cancer: a single-institution long follow-up cohort study.Hypertension and subsequent genitourinary and gynecologic cancers risk: a population-based cohort studyMetabolic syndrome and risk of cancer: a systematic review and meta-analysis.Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer.Association between metabolic syndrome, obesity, diabetes mellitus and oncological outcomes of bladder cancer: a systematic review.Obesity, Physical Activity and Bladder Cancer.Dietary patterns and risk of urinary tract tumors: a multilevel analysis of individuals in rural and urban contexts.Metabolic syndrome and esophageal and gastric cancer.Impact of body mass on recurrence and progression in Chinese patients with Ta, T1 urothelial bladder cancer.Influence of diabetes on the risk of urothelial cancer according to body mass index: a 10-year nationwide population-based observational study.Anthropometric measures and bladder cancer risk: a prospective study in the EPIC cohort.Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Guérin Treatment.Hypertension predicts a poor prognosis in patients with esophageal squamous cell carcinoma.Visceral obesity, metabolic syndrome, insulin resistance and cancerThe Association between Metabolic Syndrome and High-Stage Primary Urothelial Carcinoma of the Bladder
P2860
Q26825147-AE364B6D-11F7-445E-B2FF-F63D16D46164Q28072861-B3A7CA07-18BC-420C-908A-5000BB24B395Q31152938-1CAA925B-3EC0-44E4-B6C7-ECF7BCBBFAE9Q33779749-E161F07F-DCC9-46E3-BB66-BC3E06CA5908Q34468387-1AEA15B2-10A1-4149-9327-4382AEC40D8DQ34479248-FD4A9EEC-E87C-4ED6-8C4C-D67B04EAC66EQ34978108-6FCBB8ED-4622-4086-85A5-F749456C8EF2Q35133640-00808451-D39F-405C-9063-CA4BC3B89BEFQ35810977-6AA2101F-BFD4-4922-A5BE-6D4DE299DA60Q35923260-1BBDE439-86B9-46F9-86E5-5D542144B8E3Q36008915-C13B6048-31AB-487D-830B-7C44BD53A1EBQ36152066-C5F70D93-2836-49F3-B5AA-A0A31047CD97Q36334568-615D4BEF-89DA-41C2-BEAE-842F27EAE371Q37577156-678ECA68-587D-445B-BC24-465DCFBF45A5Q38262803-371BFB79-C11E-4D41-9298-6637CD1813D3Q38573075-F371EF6F-1666-46D3-BCF0-89E747A9FD6FQ40154431-3404DDF9-5DD2-41AE-B231-D31E223F8C7DQ40450265-2AF0A5B0-AA04-4F8D-B09D-A9E5C09748D4Q40903985-FF951F19-A74B-4177-91E5-133C8EA23239Q50306159-23AF4E24-A5A2-4E4A-AE8C-E820F19836FCQ51143339-03EA3034-EEBA-4987-8638-8E5F26BA956BQ52632425-28E8AA7D-AA6A-43E8-832E-EE00B550A365Q55196910-1A11E359-4490-402A-8B95-EDA89F65DCE3Q57521562-5A35739B-E6FA-45EC-ACAC-3551704F59BDQ58124368-01F7F365-71A2-451B-BC18-E1A3D430E637
P2860
Metabolic syndrome and risk of bladder cancer: prospective cohort study in the metabolic syndrome and cancer project (Me-Can).
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Metabolic syndrome and risk of ...... e and cancer project (Me-Can).
@en
Metabolic syndrome and risk of ...... ic syndrome and cancer project
@nl
type
label
Metabolic syndrome and risk of ...... e and cancer project (Me-Can).
@en
Metabolic syndrome and risk of ...... ic syndrome and cancer project
@nl
prefLabel
Metabolic syndrome and risk of ...... e and cancer project (Me-Can).
@en
Metabolic syndrome and risk of ...... ic syndrome and cancer project
@nl
P2093
P2860
P50
P356
P1476
Metabolic syndrome and risk of ...... e and cancer project (Me-Can).
@en
P2093
Anders Engeland
Hanno Ulmer
Hans Concin
Håkan Jonsson
Jonas Manjer
Kilian Rapp
Pär Stattin
Randi Selmer
Steinar Tretli
Tanja Stocks
P2860
P304
P356
10.1002/IJC.25521
P577
2011-04-01T00:00:00Z